The store will not work correctly when cookies are disabled.
(S)-3-Hydroxy-2-oxo-1-phenylpyrrolidine-3-carboxylic Acid 2-Fluorobenzylamide
ID: ALA4556036
PubChem CID: 89893288
Max Phase: Preclinical
Molecular Formula: C18H17FN2O3
Molecular Weight: 328.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCc1ccccc1F)[C@@]1(O)CCN(c2ccccc2)C1=O
Standard InChI: InChI=1S/C18H17FN2O3/c19-15-9-5-4-6-13(15)12-20-16(22)18(24)10-11-21(17(18)23)14-7-2-1-3-8-14/h1-9,24H,10-12H2,(H,20,22)/t18-/m0/s1
Standard InChI Key: IQELGVVHVJRQOZ-SFHVURJKSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
37.3799 -26.2571 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.1798 -26.4738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9674 -25.6728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8951 -28.9816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8938 -29.8087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6086 -30.2216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3248 -29.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3220 -28.9779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6068 -28.5689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5984 -27.7431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.2642 -27.2563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0070 -26.4726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9297 -27.2603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1460 -27.5176 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.5522 -25.0911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1713 -25.4571 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.3484 -25.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9332 -24.7251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7289 -24.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3133 -24.3622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1023 -23.5639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3012 -23.3497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7202 -23.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9389 -25.7408 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 1
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
11 12 1 0
12 2 1 0
2 13 1 0
13 10 1 0
9 10 1 0
13 14 2 0
3 15 1 0
3 16 2 0
15 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
19 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 328.34 | Molecular Weight (Monoisotopic): 328.1223 | AlogP: 1.61 | #Rotatable Bonds: 4 |
Polar Surface Area: 69.64 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.76 | CX Basic pKa: ┄ | CX LogP: 1.50 | CX LogD: 1.50 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.84 | Np Likeness Score: -1.05 |
References
1. Heinrich T, Seenisamy J, Blume B, Bomke J, Calderini M, Eckert U, Friese-Hamim M, Kohl R, Lehmann M, Leuthner B, Musil D, Rohdich F, Zenke FT.. (2019) Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors., 62 (10): [PMID:30939017] [10.1021/acs.jmedchem.9b00041] |